Abstract
Background Antenatal care and delivery with skilled attendants substantially improve maternal health outcomes across the pregnancy spectrum, from conception to delivery. The Sustainable Development Goals recognize the need to expand these services to all pregnant women but there is limited data on access for migrants and in post-conflict regions.
Methods Using geographic information systems established for malaria elimination efforts in Kayin state, Myanmar and Tak Province, Thailand, retrospective estimates of travel distances from home villages to maternal health facilities between 2007-2015 were made. Multivariable regressions were used to assess the relationships between distance to healthcare and 1) presentation for early pregnancy care, 2) complications during pregnancy like malaria infections, and 3) eventual outcome of the pregnancy.
Findings Women who delayed antenatal care until the third trimester travelled 46% farther (DR: 1.46; CI: 1.39 – 1.53) compared to women who attended in the first trimester, and those with pregnancies complicated by Plasmodium falciparum malaria travelled 62% farther (DR: 1.62; CI: 1.44 – 1.82) than those without P. falciparum. Women did not deliver with skilled birth services and were lost to follow-up travelled 45% farther (distance ratio (DR): 1.45; CI: 1.40 – 1.51) than those who followed-up to deliver with skilled birth services.
Interpretation This analysis supports substantial global evidence that travel distance disrupts access to care in limited resource regions. This is the first demonstration of empirical distance impacting maternal healthcare from early pregnancy to delivery of migrants living in post-conflict Thailand-Myanmar border regions, and future interventions should provide decentralized maternal healthcare to address these barriers.
Funding The Bill & Melinda Gates Foundation and the Wellcome Trust
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The Bill & Melinda Gates Foundation and the Wellcome Trust
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
For the extraction of data, ethical approval for retrospective analysis of pregnancy records was given by the Oxford Tropical Research Ethics Committee (OXTREC 28;09, amended 19 April 2012) and by the local Community Advisory Board TCAB 4/1/2015.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
(ericaste{at}med.umich.edu), (myochit{at}shoklo-unit.com), (micho{at}shoklo-unit.com), (sam{at}shoklo-unit.com), (mookhopaw{at}shoklo-unit.com), (emsmru{at}gmail.com), (mkt-mt{at}shoklo-unit.com), (ayemin{at}shoklo-unit.com), (naywintun{at}shoklo-unit.com), (mellietyros{at}gmail.com), (francois{at}tropmedres.ac), (rose{at}shoklo-unit.com), (dparker1{at}hs.uci.edu)
Data Availability
Access to the data used in this analysis can be requested through the Mahidol-Oxford Tropical Medicine Research Unit data access policy. Both the policy and application form are available at: http://www.tropmedres.ac/data-sharing.
